{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"4","upperLimit":"103","value":"13"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"10"}],"units":"Participants"}],"description":"Count endpoint: number of days enrolled on hospice","dispersionType":"Full Range","groups":[{"description":"Patients with aggressive hematologic malignancies who are hospice eligible, not pursuing further cancer directed therapy, and whose primary hematologist is planning to initiate a conversation regarding transition to hospice will be eligible for enrollment.\n\nTransfusion support: Patients will be offered symptom-driven transfusion support in addition to standard hospice care","id":"OG000","title":"Intervention Arm"}],"paramType":"MEDIAN","reportingStatus":"POSTED","timeFrame":"From enrollment until death or withdrawal of consent, on average 2 months.","title":"Time Enrolled on Hospice.","type":"SECONDARY","unitOfMeasure":"days"}